Kasam, R. K., Reddy, G. B., Jegga, A. G., & Madala, S. K. (2019). Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy. Front Pharmacol.
Citação norma ChicagoKasam, Rajesh K., Geereddy B. Reddy, Anil G. Jegga, e Satish K. Madala. "Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy." Front Pharmacol 2019.
Citação norma MLAKasam, Rajesh K., Geereddy B. Reddy, Anil G. Jegga, e Satish K. Madala. "Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy." Front Pharmacol 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.